Two new drugs, Jardiance and Synjardy, have been approved by the FDA to treat type 2 diabetes in children over the age of 10. These drugs provide an alternative to metformin, which was previously the only approved treatment for children. Type 2 diabetes in children is rare but can lead to serious health complications if left untreated. The drugs work to lower blood sugar levels and have been shown to be effective in reducing A1C scores in kids. These approvals provide new options for treatment for children with type 2 diabetes who may not be able to tolerate metformin.
Source link
Jardiance and Synjardy Approved for Kids Aged Ten and Up
